Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib in Advanced Liver Fibrosis
NCT05224128Phase 2Unknown
- Sponsor
- Research Institute for Gastroenterology and Liver Diseases
- Start
- Feb 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in Liver Fibrosis (LF), sponsored by Research Institute for Gastroenterology and Liver Diseases. Status: unknown.
02
Drugs
03
Conditions
Liver Fibrosis (LF)
Beyond the preview
Go deeper on NCT05224128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05224128.